| Zugriffe | |
|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 399 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 27 | 10 | 11 | 21 | 19 | 21 | 18 |
| Zugriffe | |
|---|---|
| 2021_Correll_etal.pdf | 7741 |
